Cargando…
Novel Honokiol-eluting PLGA-based scaffold effectively restricts the growth of renal cancer cells
Renal Cell Carcinoma (RCC) often becomes resistant to targeted therapies, and in addition, dose-dependent toxicities limit the effectiveness of therapeutic agents. Therefore, identifying novel drug delivery approaches to achieve optimal dosing of therapeutic agents can be beneficial in managing toxi...
Autores principales: | Hamedani, Yasaman, Chakraborty, Samik, Sabarwal, Akash, Pal, Soumitro, Bhowmick, Sankha, Balan, Murugabaskar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746163/ https://www.ncbi.nlm.nih.gov/pubmed/33332399 http://dx.doi.org/10.1371/journal.pone.0243837 |
Ejemplares similares
-
A Novel Combination Treatment with Honokiol and Rapamycin Effectively Restricts c-Met-Induced Growth of Renal Cancer Cells, and also Inhibits the Expression of Tumor Cell PD-L1 Involved in Immune Escape
por: Sabarwal, Akash, et al.
Publicado: (2020) -
A novel combination therapy with Cabozantinib and Honokiol effectively inhibits c-Met-Nrf2-induced renal tumor growth through increased oxidative stress
por: Rawat, Laxminarayan, et al.
Publicado: (2023) -
Honokiol inhibits c-Met-HO-1 tumor-promoting pathway and its cross-talk with calcineurin inhibitor-mediated renal cancer growth
por: Balan, Murugabaskar, et al.
Publicado: (2017) -
Activation of c-Met in cancer cells mediates growth-promoting signals against oxidative stress through Nrf2-HO-1
por: Chakraborty, Samik, et al.
Publicado: (2019) -
Delivery of a mitochondria‐targeted antioxidant from biocompatible, polymeric nanofibrous scaffolds
por: Hamedani, Yasaman, et al.
Publicado: (2020)